Washington, DC
November 24, 2006
The U.S. Department of
Agriculture’s Animal and Plant Health Inspection Service
(APHIS) today announced that after a thorough review of
scientific evidence it will deregulate genetically engineered
LLRICE601 based on the fact that it is as safe as its
traditionally bred counterparts. The final environmental
assessment is available on the APHIS web site at
http://www.aphis.usda.gov/brs/aphisdocs/06_23401p_ea.pdf and
will be published in the Federal Register on December 1.
On July 31, 2006 Bayer CropScience notified USDA and the U.S.
Food and Drug Administration (FDA) that the company had detected
trace amounts of this regulated rice in commercial long-grain
rice. FDA has concluded that the presence of LLRICE601 in the
food and feed supply poses no safety concerns. An investigation
to determine the circumstances surrounding the release and
whether any USDA regulations were violated is nearly complete.
Deregulation, or regulatory approval of a particular product, is
handled separately from determinations of compliance with APHIS
regulations. USDA has approved LLRICE601 for deregulation, while
an investigation of compliance is on-going.
Bayer submitted a petition to APHIS to deregulate LLRICE601,
which was engineered to be tolerant to herbicides marketed under
the brand name LibertyLink. APHIS deregulated two similar
LibertyLink rice lines, LLRICE62 and LLRICE06, in 1999 after
thorough safety evaluations and is extending its deregulation
from the original two lines to include LLRICE601. This protein
has been scientifically reviewed and approved for use in a dozen
countries around the world.
APHIS published a Sept. 8 notice in the Federal Register seeking
public comment on Bayer’s petition. The public comment period
closed Oct. 10.
APHIS oversees the development and introduction (importation,
interstate movement, and environmental release) of GE organisms.
Deregulated items and their progeny are considered safe for the
environment and can be grown without APHIS oversight. Developers
may also need to consult with FDA and the Environmental
Protection Agency before commercialization. |